MedPath

How Body mass index effects the risk of uterine cancer in perimenopausal wome

Not Applicable
Conditions
Health Condition 1: N958- Other specified menopausal and perimenopausal disorders
Registration Number
CTRI/2019/01/016993
Lead Sponsor
Samatha polisetti
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Perimenopausal women of 40-50 years who undergo endometrial sampling in view of abnormal uterine bleeding

Exclusion Criteria

prior known diagnosis of endometrial atypia and perimenopausal woman who are not subjected to invasive testing and biopsy and are being managed medically

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
number of cases with histopathological diagnosis of endometrium with endometrial atypia or cancer . BMITimepoint: 1 year
Secondary Outcome Measures
NameTimeMethod
whether bmi is a risk factor for hyperplasia or atypiaTimepoint: 1 year
© Copyright 2025. All Rights Reserved by MedPath